Maria Skłodowska-Curie National Research Institute of Oncology
Maria Skłodowska-Curie National Research Institute of Oncology
Warsaw, Poland2 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Vortosiran for VTE Prevention | Embolism, Embolism and Thrombosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thromboembolism, cancer, cardiovascular disorder, disease, lung disorder, neoplasm, pulmonary embolism, respiratory system disorder, vascular disorder, venous thromboembolism | Not yet recruiting | Phase 2 | 2026-09-30 | NCT07850453 | |
| A Study of NTX-1088, a Monoclonal Antibody Targeting the Poliovirus Receptor (PVR, CD155), as Monotherapy and Combined With Pembrolizumab | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cancer, metastatic malignant neoplasm, neoplasm | Active, not recruiting | Phase 1 | 2026-04-30 | NCT05378425 |